Skip to main content
Log in

Angiotensinogen impairs angiogenesis in the chick chorioallantoic membrane

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

Angiotensinogen shares with other members of the serine protease inhibitor (serpin) family antiangiogenic properties. Angiotensinogen inhibits in vitro endothelial cell proliferation, and is antiangiogenic in ovo in the chick chorioallantoic membrane assay. The cellular mode of action of angiotensinogen has been studied by applying purified human angiotensinogen or Chinese hamster ovary cells producing recombinant angiotensinogen onto the developing chorioallantoic membrane. Vessel density of the control and angiotensinogen-treated areas was quantitated by using Sambucus nigra lectin, a specific endothelial cell marker. After 48 h of angiotensinogen treatment by either applying purified angiotensinogen or angiotensinogen-producing Chinese hamster ovary cells, there was a 70% decrease in mesodermic vessel density in comparison to the control sections. Angiotensinogen treatment induced a strong decrease in endothelial cell proliferation of the chorioallantoic membrane vasculature, as shown by incorporation of bromo-deoxyuridine. Two days after local angiotensinogen treatment, increased apoptosis of endothelial cells of mesodermal blood vessels was detected by transferase-mediated deoxyuridine triphosphate nick end labeling assay. As assessed by in situ hybridization, the gene expression pattern of the main vascular growth factors and their receptors was not altered by angiotensinogen. Angiotensinogen, therefore, impairs angiogenesis without altering the expression level of vascular growth factors through the induction of apoptosis and decreased endothelial cell proliferation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Tewksbury DA (1990) Angiotensinogen: biochemistry and molecular biology. In: Laragh JH, Brenner BM (eds) Hypertension. Raven, New York, pp 1197–1216

    Google Scholar 

  2. Celerier J, Schmid G, Le Caer JP, Gimenez-Roqueplo AP, Bur D, Friedlein A, Langen H, Corvol P, Jeunemaitre X (2000) Characterization of a human angiotensinogen cleaved in its reactive center loop by a proteolytic activity from Chinese hamster ovary cells. J Biol Chem 275:10648–10654

    Article  PubMed  CAS  Google Scholar 

  3. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263:526–529

    Article  PubMed  CAS  Google Scholar 

  4. Zhang M, Volpert O, Shi YH, Bouck N (2000) Maspin is an angiogenesis inhibitor. Nat Med 6:196–199

    Article  PubMed  CAS  Google Scholar 

  5. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285:245–248

    Article  PubMed  CAS  Google Scholar 

  6. Miao RQ, Agata J, Chao L, Chao J (2002) Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood 100:3245–3252

    Article  PubMed  CAS  Google Scholar 

  7. Larsson H, Sjoblom T, Dixelius J, Ostman A, Ylinenjarvi K, Bjork I, Claesson-Welsh L (2000) Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells. Cancer Res 60:6723–6729

    PubMed  CAS  Google Scholar 

  8. Celerier J, Cruz A, Lamande N, Gasc JM, Corvol P (2002) Angiotensinogen and its cleaved derivatives inhibit angiogenesis. Hypertension 39:224–228

    Article  PubMed  CAS  Google Scholar 

  9. Bouquet C, Lamandé N, Brand M, Gasc JM, Jullienne B, Faure G, Griscelli F, Opolon P, Connault E, Perricaudet M, Corvol P (2006) Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen. Mol Ther 14:175–182

    Article  PubMed  CAS  Google Scholar 

  10. Auerbach R, Kubai L, Knighton D, Folkman J (1974) A simple procedure for the long-term cultivation of chicken embryos. Dev Biol 41:391–394

    Article  PubMed  CAS  Google Scholar 

  11. Wei L, Gaillard I, Corvol P, Clauser E (1988) Expression and characterization of recombinant human angiotensinogen in a heterologous eukaryotic cell line. Biochem Biophys Res Commun 156:1103–1110

    Article  PubMed  CAS  Google Scholar 

  12. Gimenez-Roqueplo AP, Leconte I, Cohen P, Simon D, Guyene TT, Celerier J, Pau B, Corvol P, Clauser E, Jeunemaitre X (1996) The natural mutation Y248C of human angiotensinogen leads to abnormal glycosylation and altered immunological recognition of the protein. J Biol Chem 271:9838–9844

    Article  PubMed  CAS  Google Scholar 

  13. Parnot C, Le Moullec JM, Cousin MA, Guedin D, Corvol P, Pinet F (1997) A live-cell assay for studying extracellular and intracellular endothelin-converting enzyme activity. Hypertension 30:837–844

    PubMed  CAS  Google Scholar 

  14. Genain C, Bouhnik J, Tewksbury D, Corvol P, Menard J (1984) Characterization of plasma and cerebrospinal fluid human angiotensinogen and des-angiotensin I-angiotensinogen by direct radioimmunoassay. J Clin Endocrinol Metab 59:478–484

    Article  PubMed  CAS  Google Scholar 

  15. Cruz A, Parnot C, Ribatti D, Corvol P, Gasc JM (2001) Endothelin-1, a regulator of angiogenesis in the chick chorioallantoic membrane. J Vasc Res 38:536–545

    Article  PubMed  CAS  Google Scholar 

  16. Larger E, Marre M, Corvol P, Gasc JM (2004) Hyperglycemia-induced defects in angiogenesis in the chicken chorioallantoic membrane model. Diabetes 53:752–761

    Article  PubMed  CAS  Google Scholar 

  17. Sibony M, Commo F, Callard P, Gasc JM (1995) Enhancement of mRNA in situ hybridization signal by microwave heating. Lab Invest 73:586–591

    PubMed  CAS  Google Scholar 

  18. Favier J, Kempf H, Corvol P, Gasc JM (1999) Cloning and expression pattern of EPAS1 in the chicken embryo. Colocalization with tyrosine hydroxylase. FEBS Lett 462:19–24

    Article  PubMed  CAS  Google Scholar 

  19. Kempf H, Linares C, Corvol P, Gasc JM (1998) Pharmacological inactivation of the endothelin type A receptor in the early chick embryo: a model of mispatterning of the branchial arch derivatives. Development 125:4931–4941

    PubMed  CAS  Google Scholar 

  20. Ribatti D, Nico B, Vacca A, Roncali L, Burri PH, Djonov V (2001) Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat Rec 264:317–324

    Article  PubMed  CAS  Google Scholar 

  21. Romanoff A (1960) The Avian Embryo. Structural and functional development. The Macmillan Company, New York

    Google Scholar 

  22. le Noble F, Fleury V, Pries A, Corvol P, Eichmann A, Reneman RS (2005) Control of arterial branching morphogenesis in embryogenesis: go with the flow. Cardiovasc Res 65:619–628

    Article  PubMed  CAS  Google Scholar 

  23. le Noble FA, Kessels-van Wylick LC, Hacking WJ, Slaaf DW, oude Egbrink MG, Struijker-Boudier HA (1996) The role of angiotensin II and prostaglandins in arcade formation in a developing microvascular network. J Vasc Res 33:480–488

    PubMed  Google Scholar 

  24. Brand M, Lamandé N, Sigmund CD, Larger E, Corvol P, Gasc JM (2006) Angiotensinogen modulates renal vasculature growth. Hypertension 47:1067–1074

    Article  PubMed  CAS  Google Scholar 

  25. Machado RD, Santos RA, Andrade SP (2000) Opposing actions of angiotensins on angiogenesis. Life Sci 66:67–76

    Article  PubMed  CAS  Google Scholar 

  26. Cher ML, Biliran HR Jr, Bhagat S, Meng Y, Che M, Lockett J, Abrams J, Fridman R, Zachareas M, Sheng S (2003) Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc Natl Acad Sci U S A 100:7847–7852

    Article  PubMed  CAS  Google Scholar 

  27. Biliran H Jr, Sheng S (2001) Pleiotropic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res 61:8676–8682

    PubMed  CAS  Google Scholar 

  28. Blacque OE, Worrall DM (2002) Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J Biol Chem 277:10783–10788

    Article  PubMed  CAS  Google Scholar 

  29. Jiménez B, Volpert OV (2001) Mechanistic insights on the inhibition of tumor angiogenesis. J Mol Med 78:663–672

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The authors thank Marie-Thérèse Morin, Francoise Mongiat and Calaiselvy Soundaramourty for an excellent technical assistance and Eric Etienne for the help with electronmicroscopy. M.B. was supported by fellowships from the Deutsche Forschungsgemeinschaft (BR 2262/1-1) and the Collège de France.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-Marie Gasc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brand, M., Lamandé, N., Larger, E. et al. Angiotensinogen impairs angiogenesis in the chick chorioallantoic membrane. J Mol Med 85, 451–460 (2007). https://doi.org/10.1007/s00109-006-0141-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-006-0141-6

Keywords

Navigation